Roles of X-box binding protein 1 in liver pathogenesis
Clinical and Molecular Hepatology · 2025
DOI: 10.3350/cmh.2024.0441 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, 2025. Verfasst von Jihoon Tak und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang, Korea. Hauptthemen laut MEDLINE: X-Box Binding Protein 1, Liver, Liver Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 303 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.
Abstract (Originalsprache)
The prevalence of drug-induced liver injury (DILI) and viral liver infections presents significant challenges in modern healthcare and contributes to considerable morbidity and mortality worldwide. Concurrently, metabolic dysfunctionassociated steatotic liver disease (MASLD) has emerged as a major public health concern, reflecting the increasing rates of obesity and leading to more severe complications such as fibrosis and hepatocellular carcinoma. X-box binding protein 1 (XBP1) is a distinct transcription factor with a basic-region leucine zipper structure, whose activity is regulated by alternative splicing in response to disruptions in endoplasmic reticulum (ER) homeostasis and the unfolded protein response (UPR) activation. XBP1 interacts with a key signaling component of the highly conserved UPR and is critical in determining cell fate when responding to ER stress in liver diseases. This review aims to elucidate the emerging roles and molecular mechanisms of XBP1 in liver pathogenesis, focusing on its involvement in DILI, viral liver infections, MASLD, fibrosis/cirrhosis, and liver cancer. Understanding the multifaceted functions of XBP1 in these liver diseases offers insights into potential therapeutic strategies to restore ER homeostasis and mitigate liver damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang, Korea.
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
Zitieren
APA
Tak, J., Kim, Y. S., & Kim, S. G. (2025). Roles of X-box binding protein 1 in liver pathogenesis. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0441
Vancouver
Tak J, Kim YS, Kim SG. Roles of X-box binding protein 1 in liver pathogenesis. Clinical and Molecular Hepatology. 2025. doi:10.3350/cmh.2024.0441
BibTeX
@article{Tak2025,
author = {Tak, Jihoon and Kim, Yun Seok and Kim, Sang Geon},
title = {Roles of X-box binding protein 1 in liver pathogenesis},
journal = {Clinical and Molecular Hepatology},
year = {2025},
doi = {10.3350/cmh.2024.0441}
}
EUVIMED